Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip - Concepedia

Concepedia

Publication | Open Access

Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip

DOI Full Paper Access

12

Citations

22

References

2024

Year

Janet D. Conway, Ronald E. Delanois, Michael A. Mont, Alexandra I. Stavrakis, Edward J. McPherson, Edward Stolarski, Stephen J. Incavo, Daniel A. Oakes, Ralph Salvagno, John S. Adams,

Antimicrobial Agents and Chemotherapy

Abstract

This study is registered with ClinicalTrials.gov as NCT04763759.

References

	Year	Citations

Page 1